Treatment of Mild Peripheral Neuropathy

First-Line Treatment Options

The American Diabetes Association recommends duloxetine (60 mg daily) or pregabalin (150-300 mg daily) as first-line treatments for mild peripheral neuropathy due to their effectiveness and relatively low side effects 1, 2, 3.
Duloxetine has a starting dose of 60 mg once daily, which can be increased to 120 mg if needed, with a Number Needed to Treat (NNT) of 5.2 for 60 mg/day and 4.9 for 120 mg/day, meaning about 1 in 5 patients will experience 50% pain relief 2, 4, 5.
Pregabalin has a starting dose of 150 mg daily, with a maximum dose of 600 mg daily, and an NNT of 5.99 for 300 mg/day and 4.04 for 600 mg/day, indicating its effectiveness in pain management 2, 4, 5.

Tricyclic antidepressants (TCAs) like amitriptyline or nortriptyline can be used as second-line options, starting with 10 mg and increasing up to 75 mg daily, with an NNT of 1.5-3.5, showing their high efficacy in pain relief 1, 4, 6.
TCAs have major side effects including anticholinergic effects, drowsiness, and orthostatic hypotension, and are contraindicated in patients with glaucoma, cardiovascular disease, or at risk of falls 2, 4, 6.

Capsaicin cream (0.075%) can be applied 3-4 times a day to the affected area, with caution that pain may increase in the first 2-3 weeks before relief is achieved, and has the advantage of no systemic side effects 2.
Lidocaine patches are useful for localized pain with minimal side effects 4.

Lifestyle modifications such as blood sugar control, regular exercise, and weight management are crucial in managing neuropathy, with evidence suggesting that these measures can improve nerve function and reduce pain 4.
Physical measures like wearing loose-fitting shoes and cotton socks, soaking feet in cold water, and regular walking can provide temporary relief and improve blood circulation 4.

A step-by-step approach to treatment involves starting with duloxetine or pregabalin, assessing pain after 2-4 weeks, and adjusting the dose or switching to another first-line medication if adequate relief is not achieved, with consideration of combination therapy or topical agents for refractory cases 2, 4, 5.

Elderly patients require special precautions, including starting with low doses and gradually increasing them, due to the increased risk of falls and side effects from TCAs and gabapentinoids 2, 4.
Monitoring of pain levels, side effects, weight gain, edema, and blood pressure is essential, with adjustments to medication as needed to ensure tolerability and efficacy 2, 4, 5.
Opioids should generally be avoided for long-term use due to the risk of dependency and constipation, and acetyl-L-carnitine should be avoided due to lack of evidence for its benefit 1, 8.